La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Utah Medical Products Gestione

Gestione criteri di controllo 3/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Kevin Cornwell

Amministratore delegato

US$510.6k

Compenso totale

Percentuale dello stipendio del CEO	29.8%
Mandato del CEO	31.7yrs
Proprietà del CEO	5.4%
Durata media del management	Nessun dato
Durata media del Consiglio di amministrazione	27.6yrs

Aggiornamenti recenti sulla gestione

Recent updates

Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation

May 01

Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?

Mar 26

Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital

Mar 02

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 11

Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain

Jan 27

Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?

Jan 13

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?

Dec 29

Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?

Dec 15

Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?

Nov 30

Utah Medical Products declares $0.285 dividend

Nov 03

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Kevin Cornwell rispetto agli utili di Utah Medical Products?
Data	Compenso totale	Stipendio	Guadagni aziendali
Jun 30 2024	n/a	n/a	US$16m
Mar 31 2024	n/a	n/a	US$16m
Dec 31 2023	US$511k	US$152k	US$17m
Sep 30 2023	n/a	n/a	US$17m
Jun 30 2023	n/a	n/a	US$17m
Mar 31 2023	n/a	n/a	US$17m
Dec 31 2022	US$452k	US$84k	US$16m
Sep 30 2022	n/a	n/a	US$16m
Jun 30 2022	n/a	n/a	US$16m
Mar 31 2022	n/a	n/a	US$15m
Dec 31 2021	US$494k	US$156k	US$15m
Sep 30 2021	n/a	n/a	US$14m
Jun 30 2021	n/a	n/a	US$13m
Mar 31 2021	n/a	n/a	US$11m
Dec 31 2020	US$327k	US$78k	US$11m
Sep 30 2020	n/a	n/a	US$12m
Jun 30 2020	n/a	n/a	US$13m
Mar 31 2020	n/a	n/a	US$15m
Dec 31 2019	US$474k	US$156k	US$15m
Sep 30 2019	n/a	n/a	US$14m
Jun 30 2019	n/a	n/a	US$17m
Mar 31 2019	n/a	n/a	US$18m
Dec 31 2018	US$501k	US$156k	US$19m
Sep 30 2018	n/a	n/a	US$13m
Jun 30 2018	n/a	n/a	US$10m
Mar 31 2018	n/a	n/a	US$9m
Dec 31 2017	US$501k	US$156k	US$9m

Compensazione vs Mercato: La retribuzione totale di Kevin ($USD 510.57K ) è inferiore alla media delle aziende di dimensioni simili nel mercato US ($USD 1.54M ).

Compensazione vs guadagni: La retribuzione di Kevin è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Kevin Cornwell (77 yo)

31.7yrs

Mandato

US$510,570

Compensazione

Mr. Kevin L. Cornwell has been the Chairman of the Board at Utah Medical Products Inc. since 1996 and its President and Chief Executive Officer since December 1992. Mr. Cornwell has been Secretary of Utah...

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Kevin Cornwell	Chairman	31.6yrs	US$510.57k	5.42% $ 12.9m
Paul Richins	Independent Director	26.6yrs	US$29.40k	0.61% $ 1.5m
Ernst Hoyer	Independent Lead Director	28.6yrs	US$37.80k	0.14% $ 341.5k
Barbara Payne	Independent Director	27.6yrs	US$29.40k	0.14% $ 330.4k
James Beeson	Independent Director	17.5yrs	US$29.40k	0.38% $ 896.3k

27.6yrs

Durata media

77yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di UTMD è composto da personale esperto e esperto (durata media dell'incarico 27.6 anni).

Utah Medical Products Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Utah Medical Products, Inc., Annual General Meeting, May 03, 2024

Chairman notifies of intention to sell stock

Independent Director recently sold US$65k worth of stock

Insufficient new directors

Independent Director recently sold US$170k worth of stock

Independent Director notifies of intention to sell stock

Recent updates

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Second quarter dividend of US$0.30 announced

Second quarter 2024 earnings released: EPS: US$0.98 (vs US$1.16 in 2Q 2023)

Upcoming dividend of US$0.30 per share

First quarter dividend of US$0.30 announced

First quarter 2024 earnings released: EPS: US$1.09 (vs US$1.16 in 1Q 2023)

Utah Medical Products, Inc., Annual General Meeting, May 03, 2024

Full year 2023 earnings released: EPS: US$4.58 (vs US$4.53 in FY 2022)

Utah Medical Products: An Attractive, But Speculative, Prospect

Upcoming dividend of US$0.30 per share

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Fourth quarter dividend of US$0.30 announced

Full year 2023 earnings released: EPS: US$4.57 (vs US$4.53 in FY 2022)

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Upcoming dividend of US$0.30 per share at 1.5% yield

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30

Third quarter 2023 earnings released: EPS: US$1.08 (vs US$1.18 in 3Q 2022)

Upcoming dividend of US$0.29 per share at 1.3% yield

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on October 3, 2023

Second quarter 2023 earnings released: EPS: US$1.15 (vs US$1.13 in 2Q 2022)

Chairman notifies of intention to sell stock

Upcoming dividend of US$0.29 per share at 1.2% yield

Independent Director recently sold US$65k worth of stock

Utah Medical Products, Inc. Announces Quarterly Dividend Payable on July 6, 2023

Full year 2022 earnings released

Now 22% undervalued after recent price drop

Upcoming dividend of US$0.29 per share at 1.3% yield

Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on April 4, 2023

Now 21% undervalued

Full year 2022 earnings released: EPS: US$4.52 (vs US$4.06 in FY 2021)

A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)

Upcoming dividend of US$0.29 per share

Investor sentiment improved over the past week

Insufficient new directors

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on January 4, 2023

Third quarter 2022 earnings released: EPS: US$1.18 (vs US$1.15 in 3Q 2021)

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29

Utah Medical Products declares $0.29 dividend

Second quarter 2022 earnings released: EPS: US$1.12 (vs US$0.94 in 2Q 2021)

Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Independent Director recently sold US$170k worth of stock

Independent Director notifies of intention to sell stock

First quarter 2022 earnings released

Insufficient new directors

Utah Medical Products, Inc., Annual General Meeting, May 06, 2022

Full year 2021 earnings released: EPS: US$4.06 (vs US$2.95 in FY 2020)

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29

Independent Director notifies of intention to sell stock

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Inaugural dividend of US$2.00 per share

Independent Director notifies of intention to sell stock

Independent Director recently sold US$222k worth of stock

Third quarter 2021 earnings released: EPS US$1.15 (vs US$0.81 in 3Q 2020)

Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital

Upcoming dividend of US$0.28 per share

Independent Director recently sold US$176k worth of stock

Independent Director notifies of intention to sell stock

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28

Second quarter 2021 earnings released: EPS US$0.94 (vs US$0.36 in 2Q 2020)